Tuesday broker round-up
(Sharecast News) - On the Beach: Citigroup downgrades to neutral with a target price of 370p.
Read moreFri, 30th Apr 2021 07:38
(Sharecast News) - On the Beach: Citigroup downgrades to neutral with a target price of 370p.
Read moreUK BROKER RATINGS SUMMARY: Investec Cuts Barclays; Goldman Raises Next
Read moreTOP NEWS: Hikma Lifts Annual Guidance; Launches Generic Drug In US
Read moreLONDON MARKET OPEN: Pound Keeps Lid On FTSE 100 As BoE Boosts Support
Read more(Sharecast News) - Pharmaceutical company Hikma said on Thursday that the group as a whole was "performing well" and had maintained the positive momentum seen in the first half, leading it to reiterate guidance for one unit and raise it on another.
Read moreLONDON MARKET CLOSE: Strong End To Choppy Session On Tight US Poll
Read moreLONDON MARKET MIDDAY: Stocks In Europe Shake Off US Poll Uncertainty
Read moreUK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreHikma Pharmaceuticals Expands US Collaboration With Arecor
Read moreUK BROKER RATINGS SUMMARY: Goldman Raises Coca-Cola HBC And Cuts DCC
Read moreIN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback
Read moreLONDON MARKET CLOSE: Stocks Rebound Slightly As Covid-19 Fears Remain
Read moreUK WINNERS & LOSERS SUMMARY: Beazley's Virus Claims Estimate Doubles
Read moreHikma Expects To Gain FDA Approval For Advair Diskus In Early 2021
Read more